Jci_page_head_homepage_01 Jci_page_head_homepage_02
Shinichi Yoshimura, Tetsuyuki Teramoto, Michael J. Whalen, Michael C. Irizarry, Yasushi Takagi, Jianhua Qiu, Jun Harada, Christian Waeber, Xandra O. Breakefield, Michael A. Moskowitz
Published in Volume 112, Issue 8
J Clin Invest. 2003; 112(8):1202–1210 doi:10.1172/JCI16618
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 3

Differentiation of BrdU-labeled cells into neurons within the GCL of DG after TBI. BrdU was injected on days 6, 7, and 8 after CCI or sham operation, and mice were killed on day 35. Coronal brain sections stained for BrdU immunoreactivity (cy2, green) and the neuronal marker, NeuN (cy3, red) were examined by laser scanning confocal microscopy (see Methods). The BrdU/NeuN-positive cells (yellow nuclei) were more numerous in FGF-2+/+ (+/+) than in FGF-2–/– (–/–) mice (see Table 1). Tissue section coordinate, bregma –2.5 mm. Scale bar: 20 μm.